Read the complete methods, findings, and discussion in the published PDF.
Late Presentation of Multidrug-Resistant Pulmonary Tuberculosis 27 Years after Treated Intracranial Tuberculoma: A Case Report
Abstract
Reactivation of tuberculosis after decades of apparent cure is not unheard of, but multidrug-resistant disease appearing this late — particularly after a central nervous system infection — is rarely documented.
We describe a 58-year-old woman who developed fever, weight loss, and a persistent cough twenty-seven years after successful treatment of an intracranial tuberculoma. A cavitary lesion in the right upper lobe led to a diagnosis of multidrug-resistant tuberculosis, with resistance to both rifampicin and isoniazid confirmed on molecular and phenotypic testing. She began a bedaquiline-based regimen in line with current WHO guidance and went on to achieve early culture conversion along with steady clinical and radiological recovery.
This case is a reminder of how unpredictable tuberculosis latency can be, reinforces the diagnostic value of molecular testing, and confirms the effectiveness of contemporary MDR-TB regimens — while making clear that clinical vigilance should not lapse even decades after apparent cure.
Keywords
Authors & affiliations
Cite this article
Srinivasa Reddy Kesari. Late Presentation of Multidrug-Resistant Pulmonary Tuberculosis 27 Years after Treated Intracranial Tuberculoma: A Case Report. ClinSphere Journals. 2026;1(1). https://doi.org/10.5281/zenodo.22810028
References
- World Health Organization. Global tuberculosis report 2023. Geneva: WHO; 2023.
- Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med. 2013;368:745-55.
- Barry CE 3rd, Boshoff HI, Dartois V, et al. The spectrum of latent tuberculosis. Nat Rev Microbiol. 2009;7:845-55.
- Gengenbacher M, Kaufmann SH. Mycobacterium tuberculosis: success through dormancy. FEMS Microbiol Rev. 2012;36:514-32.
- Rock RB, Olin M, Baker CA, et al. Central nervous system tuberculosis. Clin Microbiol Rev. 2008;21:243-61.
Open knowledge. Shared impact.
Published under the Creative Commons Attribution 4.0 International licence. Authors retain copyright.
View original publication